Infliximab and Ulcerative Colitis

Ulcerative colitis (UC) is one of the main forms of inflammatory bowel disease. The condition causes the colon and rectum to become inflamed and ulcerated.

JCM, Free Full-Text

Biologics trials evidences in ulcerative colitis

Infliximab

Infliximab Loss-of Response (LOR) in Ulcerative Colitis by

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

PDF) Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis

Crohn's & Colitis Foundation on X: The FDA approved Celltrion USA's ZYMFENTRA® (infliximab-dyyb), the first and only subcutaneous infliximab injection, for the treatment of moderate to severe ulcerative colitis and Crohn's disease.

Pharmaceutics, Free Full-Text

Ulcerative colitis: management in adults, children and young people – concise guidance

REMICADE® (infliximab) for Moderately to Severely Active Adult UC

Intestine Ulcerative Colitis Stock Vector By ©Pikovit, 46% OFF